[News Brief] Amplexd Therapeutics Starts Phase 2 HPV Trial
Amplexd Therapeutics has received authorisation from the Hong Kong Department of Health to begin a Phase 2 trial of an…
Amplexd Therapeutics has received authorisation from the Hong Kong Department of Health to begin a Phase 2 trial of an…
KM Biologics, a group company of Meiji Seika Pharma, has entered into a technology collaboration with Serum Institute of India…
Singapore’s Health Sciences Authority (HSA) has announced a retail-level recall of one batch of Famodine Tablet 20mg, a therapeutic product…
Singapore’s Health Sciences Authority (HSA) has warned the public against consuming four products after detecting banned or undeclared medicinal ingredients…
Formosa Pharmaceuticals and the Singapore Eye Research Institute (SERI) have announced a research collaboration to develop ophthalmic formulations for corneal…
Formosa Pharmaceuticals and the Singapore Eye Research Institute (SERI) have entered a research collaboration to develop ophthalmic formulations for corneal…
Researchers from A*STAR and partner institutions have identified how Mycobacterium abscessus develops resistance to bacteriophage therapy and proposed a strategy…
The International Vaccine Institute (IVI) and Hilleman Laboratories have entered a strategic partnership to collaborate on the development of vaccines…
Thailand’s Food and Drug Administration has approved ravidasvir as a treatment for hepatitis C, to be used in combination with…
Griffith University and Thermo Fisher Scientific have signed a five-year Memorandum of Understanding (MoU) to support collaboration in health, biotechnology…